Overview

A Study To Explore The Effect On Inflammatory Markers After Nasal Allergen Challenge In Subjects With Seasonal Allergic Rhinitis And The Effect Of A Single Dose Of Ibuprofen Or Fluticasone Propionate On The Allergen Response.

Status:
Completed

Trial end date:
2010-04-01

Target enrollment:

Participant gender:

Summary

After a nasal allergen challenge it should be possible to measure markers of inflammation that may be useful to assess the properties of future drugs. If these markers are reproducible and impacted by the study drugs they could be useful for future drug development.

Phase:

Phase 1

Details

Lead Sponsor:

Pfizer

Treatments:

Fluticasone
Ibuprofen
Xhance